Dr. Hur's areas of clinical areas of interests include: gastroesophageal reflux disease (GERD), Barrett's esophagus, esophageal adenocarcinoma as well as gastrointestinal cancer screening. His research interest lies in outcomes research, specifically technology assessment with a focus on decision analysis and disease modeling, and the application of these methodologies to the management of cancers and pre-malignant states (e.g. dysplasia) in the gastrointestinal tract. This management includes the identification of clinical predictors, diagnostic algorithms, and the optimization of treatment.
Some of the representative projects that he has worked on include a Simulation Model of Esophageal Adenocarcinoma, a Markov Model of Duodenal Polyposis in Familial Adenomatous Polyposis (FAP), an analysis of the impact of the implementation of Virtual Colonoscopies for colorectal cancer (CRC) screening and the possible role for chemoprevention in cancer care.
- Disease model (Markov Monte-Carlo) of Barrett's esophagus and esophageal adenocarcinoma, including the evaluation of new endoscopic therapies to determine if they are cost-effective
- Quality of life and patient preferences in Barrett's esophagus
- Cost-Effectiveness of cancer chemoprevention (e.g. aspirin and/or selective COX-2 inhibitors)
- Technology assessment of "Virtual Colonoscopy" or computed tomographic colonography